Status:
COMPLETED
Follow-Up of the Prevision® Hip Stem
Lead Sponsor:
Aesculap AG
Conditions:
Periprosthetic Fracture Around Prosthetic Joint Implant
Aseptic Loosening of Prosthetic Joint
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surger...
Eligibility Criteria
Inclusion
- All patients implanted with a Prevision® hip stem at the study site between 2014 and 2019
- Written informed patient consent
Exclusion
- \- Patients \< 18 years at surgery
Key Trial Info
Start Date :
May 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04833634
Start Date
May 14 2021
End Date
June 13 2022
Last Update
November 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caritas-Krankenhaus Bad Mergentheim, Klinik für Orthopädie und Unfallchirurgie
Bad Mergentheim, Germany, 97980